Cointime

Capsida

company

About

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

  • 51 - 100

Highlights

Total Funding Amount
$50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$50M
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2019
Number Of Employee
51 - 100
Operating Status
Active

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Capsida has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Apr 29, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 29, 2021 Series A $50M 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Capsida is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A
Cointime
เนื้อหา
บริษัท